FDA User Fee Bill Faces 1st Test In Senate Panel Vote

Law360, New York (April 24, 2012, 7:33 PM EDT) -- When the U.S. Senate's top health committee sits down Wednesday to debate and vote on this year's must-pass legislation covering U.S. Food and Drug Administration user fees, members will consider a 312-page draft bill that was painstakingly written to win bipartisan support.

The draft, known as the manager's amendment, was released ahead of the Wednesday markup and includes a wide range of provisions that would expand mandatory notification of potential drug shortages, increase penalties for counterfeiting drugs, add more controls to the supply chain, loosen the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.